China SXT Pharmaceuticals (SXTC) Property, Plant & Equipment (Net) (2018 - 2026)
China SXT Pharmaceuticals (SXTC) Property, Plant & Equipment (Net) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 2.55 Bn |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 3.93 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 3.76 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 13.44 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1.93 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 2.44 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 90.50 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 1.41 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 2.96 Bn |
| 10 | China SXT Pharmaceuticals | 32,709.60 | -28.14 Mn | - | 117,103.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117,103.00 |
| Mar 31, 2026 | 117,103.00 |
| Sep 30, 2025 | 153,079.00 |
| Sep 30, 2025 | 153,079.00 |
| Mar 31, 2025 | 178,561.00 |
| Mar 31, 2025 | 178,561.00 |
| Sep 30, 2024 | 230,142.00 |
| Sep 30, 2024 | 230,142.00 |
| Mar 31, 2024 | 328,845.00 |
| Mar 31, 2024 | 328,845.00 |
| Sep 30, 2023 | 809,039.00 |
| Sep 30, 2023 | 809,039.00 |
| Mar 31, 2023 | 962,214.00 |
| Mar 31, 2023 | 962,214.00 |
| Sep 30, 2022 | 1.01 Mn |
| Sep 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.23 Mn |
| Mar 31, 2022 | 1.23 Mn |
| Sep 30, 2021 | 1.30 Mn |
| Sep 30, 2021 | 1.30 Mn |